Wordt geladen...
HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
PURPOSE: We examined associations between tumor characteristics (human epidermal growth factor receptor 2 [HER2] protein expression, HER2 gene and chromosome 17 copy number, hormone receptor status) and disease-free survival (DFS) of patients in the N9831 adjuvant trastuzumab trial. PATIENTS AND MET...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Clinical Oncology
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2954132/ https://ncbi.nlm.nih.gov/pubmed/20697084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.2154 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|